Quick answer
TMS is an effective, well-supported treatment for conditions including major depression, anxiety, and obsessive-compulsive disorder (OCD), though exactly how effective depends on the type of study you’re looking at.
Real-world clinical registries that track people in ordinary practice tend to show the highest response and remission rates, with some reporting response rates above 55%.In simple terms: when TMS is studied out in everyday clinics rather than strict lab trials, more than half of people see meaningful improvement.
Introduction
No single overall success rate figure exists for TMS treatment. Search for “TMS success rate,” and you’ll find numbers ranging from the mid-teens to over 70%. This is because a large and growing body of research exists on TMS; studies across different population groups and measuring different outcomes will show different success rates.
Here’s how to read those numbers accurately, what predicts whether TMS is likely to work for you specifically, and what none of the statistics can tell you on their own.
Key takeaways
- Real-world clinical registries that track people in ordinary practice tend to show the highest response and remission rates within TMS research.
- Treatment response and full remission are different outcomes, and it is important to remember this when considering how effective TMS is for different conditions.
- Individual treatment outcomes are influenced by factors including baseline severity, prior treatment history, and session attendance.
- How the treatment target is chosen may affect results, though the evidence is mixed.
- You can’t predict your treatment outcome by looking at population statistics. That’s what an individual evaluation is for.
Why you will see wildly different success rates online
The core reason is variation in study design, not inconsistent evidence. There are two main types of studies on TMS:
- Sham-controlled trials compare real TMS to a fake treatment (which mimics the sensation but without any magnetic stimulation). Sham trials tend to examine a tightly controlled aspect of how TMS works and typically show lower treatment efficacy rates (15-25%) than real-world data.
- Real-world registries track thousands of people in ordinary clinics, often over long time periods, and typically show higher success rates, sometimes as high as 63%, compared to sham clinical trials.
The single most useful thing to understand before reading any number
Before drawing conclusions based on any percentage, consider what kind of study produced it.
A sham-controlled trial and a real-world registry can report very different success rates about the exact same treatment, and neither is as important to consider as your personal medical history and eligibility for TMS.
Response vs remission
These two words get used almost interchangeably online, and that’s part of why statistics on how well TMS works often seem to contradict each other.
What each term means and why the distinction matters to you
Response typically means at least a 50% reduction in symptom severity from where you started.
Remission means your symptoms have dropped further, to a level no longer considered clinically significant depression.
A treatment can have a strong response rate and a considerably smaller remission rate, and both numbers can be accurate at the same time. Knowing whether you’re reading a statistic about symptom reduction or full remission is key to interpreting any data on TMS.
What the sham-controlled trials show
The original trial supporting FDA clearance is the most rigorous kind of evidence TMS has, and it’s worth understanding exactly what it found.
Why sham control is the higher evidentiary bar
Sham-controlled trials compare real treatment against a device that provides a similar-feeling, pretend experience without delivering the therapeutic stimulation of TMS. Neither participants nor raters know who gets which, which controls for the placebo effect in a way naturalistic studies cannot.
In 2007, a pivotal multisite trial randomized 301 people to active TMS or sham treatment. At the 6-week mark, 14.2% of the active group reached remission compared with 5.2% of the sham group. This statistically significant difference became the basis for the FDA clearance of TMS.
What real-world registries show
Numbers from ordinary clinical practice look considerably higher than the sham-controlled trial findings above, and there’s a clear reason why:
Naturalistic studies track a broader population, with positively impactful care from experienced clinicians who can adjust treatment along the way. This more closely reflects what people having real-world TMS treatment actually experience.
Remission rates are typically lower than response rates:
In 2012, a multisite naturalistic study published in Depression and Anxiety tracked 307 people across 42 US clinics receiving standard clinical care rather than a controlled trial protocol. Clinician-assessed response reached a 58.0% response rate, with remission at 37.1%.
Patient-reported outcomes on the PHQ-9 (a questionnaire to assess a person’s degree of depression severity) showed a 56.4% response rate and 28.7% remission.
What predicts whether TMS works for you
A handful of individual factors influence how any specific person experiences TMS treatment, elative to average statistics about TMS success rates. These include:
Baseline symptom severity
People starting with less severe symptoms tend to have a higher likelihood of reaching remission than people starting from a more severe baseline.
Number of prior failed medication trials
A longer history of medications that didn’t help is associated with a somewhat lower likelihood of remission, though it doesn’t rule out a meaningful response.
Episode duration
A depressive episode lasting years tends to respond less predictably than a more recent episode, a pattern that shows up across depression treatments generally, not just TMS.
Session adherence and completing the full course
Since the therapeutic effect builds cumulatively across sessions, missing TMS sessions or stopping before completing a full course tends to reduce the likelihood of reaching a full response.
How targeting affects outcomes
Researchers have studied considerations and techniques for optimizing TMS coil placement, and the evidence shows precision matters.
What the comparative targeting literature suggests
In 2009, a study compared standard scalp-based coil placement (the “5-centimeter rule”) with structural MRI-guided placement and found higher response and remission rates with MRI guidance. That finding helped drive interest in more precise targeting methods.
More recent, larger research is still building out this picture. A 2025 multicenter randomized trial found no statistically significant advantage for MRI-guided neuronavigation alone over standard 5-centimeter targeting, which is why Compassion Neurohealth doesn’t rely on structural imaging alone.
By layering EEG brain mapping and HALO™ analytics on top of neuronavigation, our approach targets each person’s actual brain activity, not just anatomy. Individualized targeting remains a promising and fast-moving area of research, and we’re actively developing the personalized care we offer around it.
What the numbers do not tell you
Every statistic you read online relates to a population group. Even if you identify with the findings, unless you were in the study itself, none of them relate to you personally.
Individual variability and why no clinic can promise your result
Two people with similar diagnoses and similar histories can respond differently to the same protocol. That variability is well documented and is part of why no responsible provider promises a specific outcome before treatment starts.
How response gets measured during treatment
Your progress with TMS must be tracked directly rather than inferred from population statistics. Standardized symptom scales at set points throughout your course, along with a mid-course check-in, tell your care team how you’re doing, not how the average person does.
Find Out What Those Numbers Mean for Your Case
Population statistics are a useful starting point for a conversation about TMS. To consider whether TMS will work for you, look at factors like your baseline, medical history, and treatment adherence.
Compassion Neurohealth’s free pre-screening looks at your specific history rather than reciting a statistic and hoping it applies to you.
Frequently asked questions
Q: What Percentage of People Respond to TMS?
A: It depends on the study. Sham-controlled trials (where the control group does not have TMS) have reported response rates in the range of 15 to 25%. Real-world clinical registries, tracking ordinary people in standard practice, have reported response rates around 56 to 58%.
Q: What Is the Difference Between Response and Remission?
A: Response generally means at least a 50% reduction in symptom severity from baseline. Remission means symptoms have dropped much further, to a level no longer considered clinically significant depression. A treatment can show a strong response rate with a smaller remission rate, and that’s a normal, expected pattern rather than a contradiction.
Q: Does TMS Work if Antidepressants Have Not?
A: TMS was specifically studied in, and FDA-cleared for, people who have not found adequate relief from at least one antidepressant. Real-world data from people with an average of 2.5 prior failed medication trials still showed meaningful response and remission rates.
Q: What Happens if I Do Not Respond?
A: Your care team can review your progress data, adjust targeting or intensity, or extend your course. Not responding to a first course also doesn’t rule out response to a second course or a different protocol.
Q: Is TMS More Effective Than Medication?
A: TMS has been found to outperform traditional antidepressants in a large, multi-center trial. Even though TMS can work when medications do not, it is not a first-line treatment. People typically need to have tried medication first without relief before TMS becomes an option, further along their treatment path.
Q: How Will I Know Whether It Is Working?
A: Your care team should track your progress with standardized symptom scales at set points throughout your course, plus a mid-course check-in to get an evolving, objective read on your progress.
Q: Does TMS Work for Severe Depression?
A: TMS has been studied in people with significant depression severity, including treatment-resistant cases, and can still produce meaningful improvement. Your baseline when you start shapes the likelihood and pace of your symptom-improvement, which your evaluation can address directly.
